Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
about
Beyond CA125: the coming of age of ovarian cancer biomarkersDevelopment and preliminary evaluation of a multivariate index assay for ovarian cancer.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests.Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyTamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.Genetics: breast cancer as an exemplarImprovement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal masses.Management of genetic syndromes predisposing to gynecologic cancers.Hereditary ovarian and breast cancer: what have we learned?Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.Epigenetic biomarkers in the diagnosis of ovarian cancer.High percentage of abnormal findings on TVU needs further discussion.Familial ovarian screening--effective or ineffective?Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.Hereditary gynecologic cancers.
P2860
Q24651567-37391462-DBAC-451C-9A9E-4133350BEF8DQ30858808-266E7302-08C9-47BC-809B-1ECF47FF14E1Q34977063-F4A934A3-E45C-4E51-A08E-130E545B9D53Q35108393-915689A8-E7A3-4707-8044-8A0364C4A27EQ35596203-62518689-E0E2-4593-80D9-09B5CF137564Q35749439-08D0E464-2D35-42CD-AF4D-0EB04CBD2CACQ36240959-9B326135-1308-4170-87A0-174EC47D29A1Q36610368-E0BC5121-5178-4DCA-9F81-20A0388DAFC2Q37122297-2DFF1081-1781-41FA-8D25-A05A9DF8DD50Q37357662-9BFF7F49-06AC-4D19-9A7A-3D0643A385DEQ37407195-DB2B5299-F8C3-41D1-99A6-D516A66AD879Q37611320-6EE179B0-CA33-4CAC-A6AB-C4DC65C1FB0CQ38073703-4A1062F9-C241-4A4A-9D35-CA2A78C1F078Q38153188-AF15D33A-3950-49F1-8963-4DDD48C8969EQ38175815-CAA69AAB-E430-4D42-9EEC-F7865A91134BQ39453522-6F45490E-1E42-467F-89B1-72F4380B4892Q43199646-A9C85DCB-1132-43D6-9303-F74D64B02159Q43199656-27597A8B-CB0C-4610-89AC-EBE79DABCB3DQ44498721-DDB72650-E8AF-47AB-A5F9-103BD03DCCCBQ46109910-E6A76081-190E-43CF-98DF-1B8D48599433Q46449018-9E3937D9-E15D-4765-937B-2263D7A2B221
P2860
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@ast
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@en
type
label
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@ast
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@en
prefLabel
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@ast
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@en
P2093
P2860
P356
P1476
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
@en
P2093
Ligtenberg MJ
Massuger LF
de Hullu JA
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603015
P407
P577
2006-03-01T00:00:00Z